loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Drug Master Files (DMF) of Encorafenib Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Aurobindo Pharma Limited (1)

02 MSN Laboratories (1)

filter

01 ENCORAFENIB (2)

filter

01 India (2)

filter

01 Active (2)

filter

01 Complete (2)

URL Supplier Web Content
36630
Active
2021-12-21
Complete
2022-01-04
2021-12-20
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
35756
Active
2021-03-31
Complete
2022-04-06
2022-01-07
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1269440-17-6 / Encorafenib API manufacturers, exporters & distributors?

Encorafenib manufacturers, exporters & distributors 1

45

PharmaCompass offers a list of Encorafenib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Encorafenib manufacturer or Encorafenib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Encorafenib manufacturer or Encorafenib supplier.

PharmaCompass also assists you with knowing the Encorafenib API Price utilized in the formulation of products. Encorafenib API Price is not always fixed or binding as the Encorafenib Price is obtained through a variety of data sources. The Encorafenib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Encorafenib

Synonyms

Lgx818, 1269440-17-6, Lgx-818, Braftovi, Encorafenib (lgx818), Nvp-lgx818-nxa

Cas Number

1269440-17-6

Unique Ingredient Identifier (UNII)

8L7891MRB6

About Encorafenib

Encorafenib is an orally available Raf kinase inhibitor with potential antineoplastic activity. Encorafenib specifically inhibits Raf kinase, a serine/threonine enzyme in the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-related kinase (ERK) signaling pathway. By inhibiting the activation of the RAF/MEK/ERK signaling pathway, the administration of LGX818 may result in a decrease in proliferation of tumor cells. The Raf mutation BRAF V600E is frequently upregulated in a variety of human tumors and results in the constitutive activation of the RAF/MEK/ERK signaling pathway that regulates cellular proliferation and survival.

Encorafenib Manufacturers

A Encorafenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Encorafenib, including repackagers and relabelers. The FDA regulates Encorafenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Encorafenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Encorafenib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Encorafenib Suppliers

A Encorafenib supplier is an individual or a company that provides Encorafenib active pharmaceutical ingredient (API) or Encorafenib finished formulations upon request. The Encorafenib suppliers may include Encorafenib API manufacturers, exporters, distributors and traders.

click here to find a list of Encorafenib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Encorafenib USDMF

A Encorafenib DMF (Drug Master File) is a document detailing the whole manufacturing process of Encorafenib active pharmaceutical ingredient (API) in detail. Different forms of Encorafenib DMFs exist exist since differing nations have different regulations, such as Encorafenib USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Encorafenib DMF submitted to regulatory agencies in the US is known as a USDMF. Encorafenib USDMF includes data on Encorafenib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Encorafenib USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Encorafenib suppliers with USDMF on PharmaCompass.

Encorafenib Manufacturers | Traders | Suppliers

Encorafenib Manufacturers, Traders, Suppliers 1
57

We have 2 companies offering Encorafenib

Get in contact with the supplier of your choice:

  1. Aurobindo Pharma Limited
  2. MSN Laboratories
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY